Fluiditek syrup is used for the following indications:
The active ingredient is carbocisteine (1 ml of 2% syrup contains 20 mg of carbocisteine).
Excipients: glycerin, methyl parahydroxybenzoate (E 218), sucrose, orange-yellow dye S (E 110), banana flavor, sodium hydroxide, purified water.
children's age up to 2 years;
hypersensitivity to the active substance or to any of the excipients;
peptic ulcer of the stomach and duodenum during an exacerbation;
I trimester of pregnancy (due to insufficient data on teratogenic and embryotoxic effects).
Apply internally.
The syrup is recommended for the treatment of children under 15 years of age. For accurate dosing of the syrup, a graduated dosing cup is included. One dosing cup filled with syrup to the 1 ml mark contains 20 mg of carbocisteine.
The preparation is used in children aged 2 years and older. Children should be treated under medical supervision.
children aged 2 to 5 years - 200 mg of carbocisteine per day in 2 doses, that is, one dosing cup filled to the 5 ml mark 2 times a day;
children aged 5 to 15 years - 300 mg of carbocisteine per day in 3 divided doses, that is, one dosing cup filled to the 5 ml mark 3 times a day.
The maximum single dose of syrup for children is 100 mg of carbocisteine.
The duration of the use of carbocisteine for children should be short, no more than 5 days.
Pregnant
In animal studies, no teratogenic effects have been identified. The absence of teratogenic effects in animals means that no developmental deficiencies are expected in humans. To date, there have been no reports of a teratogenic effect in the post-registration period. There is no data on the penetration of carbocisteine into breast milk.
During pregnancy (II and III trimesters) and breastfeeding, the preparation is used after a doctor's careful assessment of the benefit to the mother / risk to the fetus (child) ratio.
Drivers
The preparation does not affect the reaction rate when driving vehicles or other mechanisms.
Symptoms: stomach pain, nausea, diarrhea.
Treatment: symptomatic therapy.
The risk of developing impaired bronchial patency in children under 2 years of age. Possible digestive disorders (stomach pain, nausea, vomiting, diarrhea). In such cases, it is recommended to reduce the dose. Allergic skin reactions are possible, such as urticaria, angioedema, pruritus, erythematous skin rashes (possibly distant in time). There have been several reported cases of fixed preparation-induced rash.
Store in its original packaging at a temperature not exceeding 25 ° C, out of the reach of children.
Shelf life is 2 years.
There are no reviews for this product.